Joseph Koziak

Joseph’s background over the past 25 years covers the acquisition, development, and commercialization of medical devices, diagnostic products, and pharmaceuticals. He has founded innovative technology companies and created successful exit strategies including IPO and M&A. He has raised equity financing and negotiated industry-leading collaborations and licensing agreements with Roche, Novartis, Atrium, Glaxo and Ubisoft.